Kiniksa Pharmaceuticals Ltd Rilonacept Analyst Day Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Rilonacept Analyst Day conference call. (Operator Instructions) Please be advised that today's conference may be recorded. (Operator Instructions)
I would now like to hand the conference to your speaker today, Mr. Mark Ragosa, Head of Investor Relations. Thank you. Please go ahead.
Good morning, and thank you for joining Kiniksa's webcast covering the burden and unmet need of recurrent pericarditis as well as the potential for rilonacept to treat patients suffering from the disease and our strategy to bring this treatment to patients. The information we present today can be found through the investors and media section of our website.
Turning to the agenda. Our CEO, Sanj Patel, will start with an introduction. We'll also hear a first-hand account of the patient journey and learn more about the burden of recurrent pericarditis, the current treatment paradigm and the unmet need from Dr. Paul Cremer of the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |